Finance

Beta
Lists
NPPNY:OTCMKTS
Nippon Shinyak Unsponsored ADR Representing Ord Shs
$6.00
0.00%
(0.00) 1D
Jun 29, 9:30:00 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NPPNY...
Mkt. cap
284.38B
Avg. vol.
50.00
Volume
3.00
52-wk high
$15.21
52-wk low
$5.03
Beta
-0.09
Shares outstanding
281.00M
No. of employees
2K
Mkt. cap
284.38B
Avg. vol.
50.00
Volume
3.00
52-wk high
$15.21
52-wk low
$5.03
Beta
-0.09
Shares outstanding
281.00M
No. of employees
2K
News stories
From sources across the web
Profile
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that markets prescription drugs and functional foods. Nippon Shinyaku has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
About Nippon Shinyak Unsponsored ADR Representing Ord Shs
CEO-
Employees2.31K
FoundedOct 1, 1919
Headquarters-
SectorPharmaceutical industry
Websitenippon-shinyaku.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
39.55B
40.10B
47.49B
43.64B
Cost of goods sold
12.66B
12.68B
16.68B
15.45B
Cost of revenue
12.66B
12.68B
16.68B
15.45B
Research and development expenses
6.19B
8.45B
8.40B
13.68B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.00B
10.36B
11.35B
10.89B
Operating expense
16.81B
17.92B
18.06B
27.55B
Total operating expenses
29.46B
30.60B
34.73B
43.00B
Operating income
10.08B
9.50B
12.75B
639.00M
Other non operating income
-2.00M
1.00M
-2.00M
323.00M
EBT including unusual items
10.50B
9.53B
13.20B
3.24B
EBT excluding unusual items
10.50B
9.53B
13.20B
3.35B
Income tax expense
2.25B
2.02B
3.11B
-642.00M
Effective tax rate
21.40%
21.19%
23.57%
-19.83%
Other operating expenses
625.00M
-888.00M
-1.68B
2.01B
Net income
8.26B
7.50B
10.08B
3.88B
Net profit margin
20.87%
18.72%
21.23%
8.88%
Earnings per share
-
-
-
-
Interest and investment income
468.00M
82.00M
464.00M
119.00M
Interest expense
-46.00M
-55.00M
-19.00M
-
Net interest expenses
422.00M
27.00M
445.00M
119.00M
Depreciation and amortization charges
-
-
-
974.00M
EBITDA
11.67B
11.14B
14.41B
2.38B
Gain or loss from assets sale
-
19.00M
56.00M
56.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer